李庆云, 孙娴雯 . 细化稳定期COPD管理流程和随访策略：2020版GOLD指南解读[J]. 诊断学理论与实践, 2020 , 19(04) : 354 -358 . DOI: 10.16150/j.1671-2870.2020.04.006
| [1] | Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2020)[R/OL]. http://goldcopd.org/. |
| [2] | Çolak Y, Nordestgaard BG, Vestbo J, et al. Prognostic significance of chronic respiratory symptoms in indivi-duals with normal spirometry[J]. Eur Respir J, 2019, 54(3):1900734. |
| [3] | Haroon S, Adab P, Riley RD, et al. Predicting risk of undiagnosed COPD: development and validation of the Target COPD score[J]. Eur Respir J, 2017, 49(6):1602191. |
| [4] | Huang WC, Wu MF, Chen HC, et al. Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study[J]. NPJ Prim Care Respir Med, 2015, 25:15063. |
| [5] | Cheng SL, Lin CH, Wang CC, et al. Comparison between COPD assessment test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients[J]. J Formos Med Assoc, 2019, 118(1 Pt 3):429-435. |
| [6] | Han MK, Quibrera PM, Carretta EE, et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort[J]. Lancet Respir Med, 2017, 5(8):619-626. |
| [7] | Benson VS, Pascoe KC, Siddall J, et al. Exacerbation frequency and eosinophil counts among patients with COPD currently prescribed triple therapy[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14:2711-2723. |
| [8] | Le Rouzic O, Roche N, Cortot AB, et al. Defining the "frequent exacerbator" phenotype in COPD: a hypothesis-free approach[J]. Chest, 2018, 153(5):1106-1115. |
| [9] | Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α(1)-antitrypsin deficiency[J]. Eur Respir J, 2017, 50(5):1700610. |
| [10] | Stockley RA, Edgar RG, Pillai A, et al. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11:1745-1756. |
| [11] | Takei N, Suzuki M, Makita H, et al. Serum alpha-1 antitrypsin levels and the clinical course of chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14:2885-2893. |
| [12] | Balbi B, Sangiorgi C, Gnemmi I, et al. Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14:1879-1893. |
| [13] | McElvaney NG, Burdon J, Holmes M, et al. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial(RAPID-OLE)[J]. Lancet Respir Med, 2017, 5(1):51-60. |
| [14] | Effing TW, Vercoulen JH, Bourbeau J, et al. Definition of a COPD self-management intervention: International Expert Group consensus[J]. Eur Respir J, 2016, 48(1):46-54. |
| [15] | Kessler R, Casan-Clara P, Koehler D, et al. COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD[J]. Eur Respir J, 2018, 51(1):1701612. |
| [16] | Rose L, Istanboulian L, Carriere L, et al. Program of integrated care for patients with chronic obstructive pulmonary disease and multiple comorbidities (PIC COPD(+): a randomised controlled trial[J]. Eur Respir J, 2018, 51(1):1701567. |
| [17] | Benzo R, McEvoy C. Effect of health coaching delivered by a respiratory therapist or nurse on self-management abilities in severe COPD: analysis of a large randomized study[J]. Respir Care, 2019, 64(9):1065-1072. |
| [18] | Cho-Reyes S, Celli BR, Dembek C, et al. Inhalation technique errors with metered-dose inhalers among patients with obstructive lung diseases: a systematic review and meta-analysis of U.S. studies[J]. Chronic Obstr Pulm Dis, 2019, 6(3):267-280. |
| [19] | Sulaiman I, Cushen B, Greene G, et al. Objective assessment of adherence to inhalers by patients with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2017, 195(10):1333-1343. |
| [20] | Alison JA, McKeough ZJ, Johnston K, et al. Australian and New Zealand Pulmonary Rehabilitation Guidelines[J]. Respirology, 2017, 22(4):800-819. |
| [21] | Horton EJ, Mitchell KE, Johnson-Warrington V, et al. Comparison of a structured home-based rehabilitation programme with conventional supervised pulmonary rehabilitation: a randomised non-inferiority trial[J]. Thorax, 2018, 73(1):29-36. |
| [22] | Nolan CM, Kaliaraju D, Jones SE, et al. Home versus outpatient pulmonary rehabilitation in COPD: a propensity-matched cohort study[J]. Thorax, 2019, 74(10):996-998. |
| [23] | Wootton SL, Hill K, Alison JA, et al. Effects of ongoing feedback during a 12-month maintenance walking program on daily physical activity in people with COPD[J]. Lung, 2019, 197(3):315-319. |
| [24] | Coultas DB, Jackson BE, Russo R, et al. Home-based physical activity coaching, physical activity, and health care utilization in chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease self-management activation research trial secondary outcomes[J]. Ann Am Thorac Soc, 2018, 15(4):470-478. |
| [25] | Gordon CS, Waller JW, Cook RM, et al. Effect of pulmonary rehabilitation on symptoms of anxiety and depression in COPD: a systematic review and meta-analysis[J]. Chest, 2019, 156(1):80-91. |
| [26] | Alison JA, McKeough ZJ, Leung RWM, et al. Oxygen compared to air during exercise training in COPD with exercise-induced desaturation[J]. Eur Respir J, 2019, 53(5):1802429. |
| [27] | Kopsaftis Z, Wood-Baker R, Poole P. Influenza vaccine for chronic obstructive pulmonary disease (COPD)[J]. Cochrane Database Syst Rev, 2018, 6(6):CD002733. |
| [28] | Gershon AS, Chung H, Porter J, et al. Influenza vaccine effectiveness in preventing hospitalizations in older patients with chronic obstructive pulmonary disease[J]. J Infect Dis, 2020, 221(1):42-52. |
| [29] | Figueira Gonçalves JM, García Bello MA, Bethencourt Martín N, et al. Impact of 13-valent pneumococcal conjugate polysaccharide vaccination on severe exacerbations in patients with chronic obstructive pulmonary di-sease and established cardiovascular disease[J]. Eur J Intern Med, 2019, 63:e14-e16. |
| [30] | Szmidt MK, Kaluza J, Harris HR, et al. Long-term dietary fiber intake and risk of chronic obstructive pulmonary disease: a prospective cohort study of women[J/OL]. Eur J Nutr, 2019-06-06[2020-02-21]. https://pubmed.ncbi.nlm.nih.gov/31280344/. |
| [31] | Gouzi F, Maury J, Héraud N, et al. Additional effects of nutritional antioxidant supplementation on peripheral muscle during pulmonary rehabilitation in COPD patients: a randomized controlled trial[J]. Oxid Med Cell Longev, 2019, 2019:5496346. |
| [32] | Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials[J]. Thorax, 2019, 74(4):337-345. |
| [33] | Costi S, Crisafulli E, Trianni L, et al. Baseline exercise tolerance and perceived dyspnea to identify the ideal candidate to pulmonary rehabilitation: a risk chart in COPD patients[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14:3017-3023. |
| [34] | Tavares-Silva E, Donatto FF, Medeiros RMV, et al. Carbohydrate supplementation and psychophysiological responses during moderate exercise in hypoxia[J]. J Int Soc Sports Nutr, 2020, 17(1):3. |
| [35] | Beaumont M, Forget P, Couturaud F, et al. Effects of inspiratory muscle training in COPD patients: a systematic review and meta-analysis[J]. Clin Respir J, 2018, 12(7):2178-2188. |
| [36] | Beaumont M, Mialon P, Le Ber C, et al. Effects of inspiratory muscle training on dyspnoea in severe COPD patients during pulmonary rehabilitation: controlled randomised trial[J]. Eur Respir J, 2018, 51(1):1701107. |
| [37] | Charususin N, Gosselink R, Decramer M, et al. Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD[J]. Thorax, 2018, 73(10):942-950. |
| [38] | Velloso M, Jardim JR. Study of energy expenditure du-ring activities of daily living using and not using body position recommended by energy conservation techniques in patients with COPD[J]. Chest, 2006, 130(1):126-132. |
| [39] | Lenferink A, Brusse-Keizer M, van der Valk PD, et al. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2017, 8(8):CD011682. |
| [40] | Howcroft M, Walters EH, Wood-Baker R, et al. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2016, 12(12):CD005074. |
/
| 〈 |
|
〉 |
